SEC Form 4 · accession 0001123292-15-001393
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sheila Gujrathi
Director
Period of report
Dec 2, 2015
Accepted (ET)
Dec 3, 2015 · 5:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $37.99 | Dec 2, 2015 | A | 25,000 | A | — | Dec 1, 2025 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1One third of the shares underlying the option will vest on each anniversary of the grant date, provided the reporting person continues to serve as a member of the Board of Directors of the Company through each such date.